Zobrazeno 1 - 10
of 126
pro vyhledávání: '"Richard C, Brunken"'
Autor:
Richard C. Brunken
Publikováno v:
Journal of Nuclear Cardiology. 29:1915-1918
Autor:
Richard C. Brunken
Publikováno v:
Journal of Nuclear Cardiology. 28:1660-1663
Autor:
Emer Joyce, Richard C. Brunken, Josephine Shaia, Logan J. Harper, Rory Hachamovitch, Karla Pearson, Barbara Bonanno, Meghann McCarthy, Manuel L. Ribeiro Neto, Daniel A. Culver
Publikováno v:
The American Journal of Cardiology. 124:1630-1635
Cardiac sarcoidosis (CS) is frequently difficult to treat. Infliximab (IFX) is useful for extracardiac sarcoidosis, but its use in CS has been limited due to concerns about cardiotoxicity and an FDA blackbox warning about use in heart failure. We rev
Autor:
Richard C, Brunken
Publikováno v:
Journal of Nuclear Cardiology
Background The clinical significance of incidentally found RV abnormalities on low-risk SPECT studies is not well-defined. The objective of this study was to determine the predictive value of incidental right ventricular (RV) abnormalities identified
Autor:
Richard C, Brunken
Publikováno v:
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology. 29(1)
Autor:
Wilson Tang, Richard C. Brunken, Roy Chung, Daniel A. Culver, Gian M. Novaro, Patrick J. Tchou
Publikováno v:
Australasian Medical Journal, Vol 11, Iss 8, Pp 410-420 (2018)
Background The diagnosis and management of cardiac sarcoidosis (CS) along with the recognition of high risk features remains a significant challenge. Failing to identify reliable disease prognosticators often results in fatal ventricular arrhythmia o
Autor:
Rory Hachamovitch, Manuel D. Cerqueira, Richard C. Brunken, Jorge Oldan, Omair Javed, Daniel A. Culver, Brett W. Sperry, Balaji Tamarappoo
Publikováno v:
JACC: Cardiovascular Imaging. 11:336-345
Objectives This study sought to evaluate the incremental value of quantifying the extent and severity of myocardial perfusion and 18F-labeled fluorodeoxyglucose (FDG) abnormalities in predicting adverse outcomes among patients with suspicion for card
Autor:
Michael N. Vranian, Wael A. Jaber, Rory Hachamovitch, Mazen Hanna, Dermot Phelan, Manuel D. Cerqueira, Brett W. Sperry, Albree Tower-Rader, Richard C. Brunken
Publikováno v:
JACC: Cardiovascular Imaging. 11:234-242
This study sought to investigate the regional uptake of technetium 99m-pyrophosphate (TcPYP) in transthyretin cardiac amyloidosis (ATTR) and its association with mortality.TcPYP nuclear scintigraphy is a diagnostic and prognostic tool in ATTR. Echoca
Autor:
Richard C. Brunken, Frank P. DiFilippo
Publikováno v:
Clinical Nuclear Medicine. 42:e103-e108
PURPOSE The benefit of time-of-flight (TOF) information in PET oncology studies is well established, demonstrating improved signal-to-noise ratio and enhanced lesion detection. In cardiac PET studies, tracer distribution and study interpretation diff
Autor:
Richard C, Brunken
Publikováno v:
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology. 28(4)